The biotechnology market is growing steadily due to personalized medicine trends, with significant investments in research and innovative therapies further propelling its expansion. Therefore, investors could consider investing in top biotech stocks, Immunocore Holdings plc (IMCR), Halozyme Therapeutics, Inc. (HALO), and Entrada Therapeutics, Inc. (TRDA).
This year, the biotech industry is expected to see AI-driven innovations and continued growth in RNA technology, CRISPR, and stem cell research, shaping drug discovery and therapeutic interventions. The global biotechnology market is estimated to grow at a CAGR of 15.5% and be worth $1.35 trillion by 2030.
